European Commission logo
Deutsch Deutsch
CORDIS - Forschungsergebnisse der EU
CORDIS

Paediatric European Risperidone Studies

Ziel

Second-generation antipsychotics are increasingly being prescribed to children and adolescents. Their use, however, is mostly off-label, and adequate and sufficient data about efficacy and particular safety are lacking. This proposal focuses on two indications, the use of risperidone in children and adolescents with conduct disorder who are not mentally retarded, and the use of risperidone in adolescents with schizophrenia. The objectives are to 1) perform a series of clinical studies that will provide sufficient information for a Paediatric Use Marketing Authorisation to be obtained for these indications; 2) address scientific questions about the moderating and/or mediating factors of the efficacy and safety of risperidone in children and adolescents, and 3) disseminate the knowledge acquired by the proposed studies to medical and mental health professionals, to patients and their families and society in general.

Wissenschaftliches Gebiet

Programm/Programme

Thema/Themen

Aufforderung zur Vorschlagseinreichung

FP7-HEALTH-2009-single-stage
Andere Projekte für diesen Aufruf anzeigen

Finanzierungsplan

CP-FP - Small or medium-scale focused research project

Koordinator

STICHTING RADBOUD UNIVERSITEIT
EU-Beitrag
€ 811 360,00
Adresse
HOUTLAAN 4
6525 XZ Nijmegen
Niederlande

Auf der Karte ansehen
Region
Oost-Nederland Gelderland Arnhem/Nijmegen
Aktivitätstyp
Higher or Secondary Education Establishments
Kontakt Verwaltung
Maarten Van Langen (Mr.)
Links
Gesamtkosten
Keine Daten

Beteiligte (20)

Diese Seite teilen

Herunterladen

Letzte Aktualisierung: 9 Februar 2022

Mein Booklet

Permalink: https://cordis.europa.eu/project/id/241959/de

European Union, 2024